TY - JOUR
T1 - Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction
T2 - Identification of myocardial stunning and hyperkinesia
AU - Christian, Timothy F.
AU - Behrenbeck, Thomas
AU - Pellikka, Patricia A.
AU - Huber, Kenneth C.
AU - Chesebro, James H.
AU - Gibbons, Raymond J.
PY - 1990/12
Y1 - 1990/12
N2 - Quantitation of perfusion defect size using tomographic imaging with technetium-99m-hexakis-2-methoxy isobutyl isonitrile was performed at the time of hospital discharge in 32 patients with a first myocardial infarction who underwent successful coronary reperfusion within 8 h of the onset of chest pain. Reperfusion was accomplished with thrombolysis or primary coronary angioplasty. Radionuclide angiography was performed at discharge and 6 weeks later. There was a close correlation between perfusion defect size and values for ejection fraction and regional wall motion both at discharge (r = -0.80 and -0.75, respectively) and 6 weeks later (r = -0.81 and -0.81, respectively). There was no overall group difference in ejection fraction between the value at discharge and at 6 weeks; however, five patients had a significant increase (≥0.08) and six had a significant decrease (≥0.08) in ejection fraction. In patients with a significant increase at 6 weeks, ejection fraction was significantly lower at discharge than the value predicted from perfusion defect size (0.37 ± 0.09 measured versus 0.47 ± 0.13 predicted, p < 0.05) and it improved at 6 weeks to near predicted values (0.51 ± 0.07). In patients with a significant decrease at 6 weeks, ejection fraction was significantly higher at discharge than the value predicted from perfusion defect size (0.60 ± 0.10 measured versus 0.50 ± 0.10 predicted, p < 0.05) and it decreased at 6 weeks to near predicted levels (0.51 ± 0.09). Left ventricular ejection fraction at the time of hospital discharge is a potentially misleading index of the efficacy of reperfusion therapy for myocardial infarction. In a significant minority (34%) of patients this index does not accurately reflect perfusion defect size, apparently because of the effects of myocardial stunning and compensatory hyperkinesia.
AB - Quantitation of perfusion defect size using tomographic imaging with technetium-99m-hexakis-2-methoxy isobutyl isonitrile was performed at the time of hospital discharge in 32 patients with a first myocardial infarction who underwent successful coronary reperfusion within 8 h of the onset of chest pain. Reperfusion was accomplished with thrombolysis or primary coronary angioplasty. Radionuclide angiography was performed at discharge and 6 weeks later. There was a close correlation between perfusion defect size and values for ejection fraction and regional wall motion both at discharge (r = -0.80 and -0.75, respectively) and 6 weeks later (r = -0.81 and -0.81, respectively). There was no overall group difference in ejection fraction between the value at discharge and at 6 weeks; however, five patients had a significant increase (≥0.08) and six had a significant decrease (≥0.08) in ejection fraction. In patients with a significant increase at 6 weeks, ejection fraction was significantly lower at discharge than the value predicted from perfusion defect size (0.37 ± 0.09 measured versus 0.47 ± 0.13 predicted, p < 0.05) and it improved at 6 weeks to near predicted values (0.51 ± 0.07). In patients with a significant decrease at 6 weeks, ejection fraction was significantly higher at discharge than the value predicted from perfusion defect size (0.60 ± 0.10 measured versus 0.50 ± 0.10 predicted, p < 0.05) and it decreased at 6 weeks to near predicted levels (0.51 ± 0.09). Left ventricular ejection fraction at the time of hospital discharge is a potentially misleading index of the efficacy of reperfusion therapy for myocardial infarction. In a significant minority (34%) of patients this index does not accurately reflect perfusion defect size, apparently because of the effects of myocardial stunning and compensatory hyperkinesia.
UR - http://www.scopus.com/inward/record.url?scp=0025651866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025651866&partnerID=8YFLogxK
U2 - 10.1016/0735-1097(90)90313-E
DO - 10.1016/0735-1097(90)90313-E
M3 - Article
C2 - 2147706
AN - SCOPUS:0025651866
SN - 0735-1097
VL - 16
SP - 1632
EP - 1638
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 7
ER -